Navidea Biopharmaceuticals Inc (NAVB)
0.035
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Navidea Biopharmaceuticals Cash from Operations (Quarterly): -10.25M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -10.25M |
| June 30, 2023 | 4.690M |
| March 31, 2023 | -1.722M |
| December 31, 2022 | -2.433M |
| September 30, 2022 | -1.858M |
| June 30, 2022 | -2.139M |
| March 31, 2022 | -2.556M |
| December 31, 2021 | -2.728M |
| September 30, 2021 | -2.012M |
| June 30, 2021 | -2.415M |
| March 31, 2021 | -3.062M |
| December 31, 2020 | -2.557M |
| September 30, 2020 | -2.631M |
| June 30, 2020 | -2.034M |
| March 31, 2020 | -0.9513M |
| December 31, 2019 | -2.733M |
| September 30, 2019 | -2.343M |
| June 30, 2019 | -2.113M |
| March 31, 2019 | -2.165M |
| December 31, 2018 | -2.127M |
| September 30, 2018 | -1.887M |
| June 30, 2018 | 10.55M |
| March 31, 2018 | -2.260M |
| December 31, 2017 | -1.962M |
| September 30, 2017 | -0.9465M |
| Date | Value |
|---|---|
| June 30, 2017 | -5.666M |
| March 31, 2017 | 67.66M |
| December 31, 2016 | 2.258M |
| September 30, 2016 | 2.656M |
| June 30, 2016 | 0.3229M |
| March 31, 2016 | -1.680M |
| December 31, 2015 | -4.195M |
| September 30, 2015 | -4.089M |
| June 30, 2015 | -6.683M |
| March 31, 2015 | -4.109M |
| December 31, 2014 | -4.826M |
| September 30, 2014 | -6.708M |
| June 30, 2014 | -8.42M |
| March 31, 2014 | -9.172M |
| December 31, 2013 | -11.16M |
| September 30, 2013 | -9.705M |
| June 30, 2013 | -7.356M |
| March 31, 2013 | -7.396M |
| December 31, 2012 | -7.319M |
| September 30, 2012 | -5.064M |
| June 30, 2012 | -4.95M |
| March 31, 2012 | -6.591M |
| December 31, 2011 | -9.715M |
| September 30, 2011 | -3.710M |
| June 30, 2011 | -0.7955M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.25M
Minimum
Sep 2023
4.690M
Maximum
Jun 2023
-2.325M
Average
-2.379M
Median
Cash from Operations (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 3.471M |
| Xtant Medical Holdings Inc | -0.915M |
| Asensus Surgical Inc | -13.37M |
| Senseonics Holdings Inc | -15.07M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.5247M |
| Cash from Financing (Quarterly) | -0.1886M |
| Free Cash Flow | -9.907M |
| Free Cash Flow Per Share (Quarterly) | -0.1033 |
| Free Cash Flow Yield | -532.4% |